Corbus Pharmaceuticals
CRBP
CRBP
70 hedge funds and large institutions have $8.04M invested in Corbus Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 13 increasing their positions, 18 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
28% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 18
59% less capital invested
Capital invested by funds: $19.7M → $8.04M (-$11.7M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
70
Holding in Top 10
–
Calls
$118K
Puts
$58K
Top Buyers
| 1 | +$118K | |
| 2 | +$69.2K | |
| 3 | +$26K | |
| 4 |
Goldman Sachs
New York
|
+$24K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$23K |
Top Sellers
| 1 | -$1.08M | |
| 2 | -$522K | |
| 3 | -$275K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$147K |
| 5 |
BlackRock
New York
|
-$47.7K |